2006 Biotechnology Business Model Operations 
Harvard Business Review
MAY 1, 2014
I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. To save the 20-year-old company, I had to get it operating like a start-up. NPS had hit a rough patch in 2006. Accordingly, I transformed the business model ?
Harvard Business Review
OCTOBER 26, 2011
Between 2006 and 2008, more than $1 billion venture-capital dollars were channeled into startups focused on solar, wind and biofuel technologies. It's easy to see why VCs have soured on the sector: the traditional VC model is based on high-risk, capital-efficient business models with the potential for huge exit valuations.
Expert insights. Personalized for you.
9 
Let's personalize your content